semaglutide vs tirzepatide results vs. Semaglutide vs Tirzepatide - Twelve

GLP-1 drugs slow digestion and blunt appetite, and for some people that means persistent nausea, rapid fullness, or a loss of interest in eating altogether

Tirzepatide offers hope for many, and with the right care and attention, side effects can be managed to maximize its benefits

Rotating between abdomen, upper arm, and thigh prevents lipodystrophy (fat tissue changes) at frequently used sites

The most common side effects of tirzepatide are gastrointestinal: Nausea: Reported by 12-33% of participants depending on dose (most common early in treatment) Diarrhea: 12-21% of participants Constipation: 6-11% of participants Vomiting: 5-13% of participants Decreased appetite: Expected therapeutic effect but can be uncomfortable These side effects are typically most intense during the first few weeks at each new dose level and tend to improve as the body adjusts

And with illegal knock-off drugs, the risks are even more serious

Persistent mild-to-moderate nausea without vomiting is common during weeks 13 at each new dose and doesn't require dose modification if you can eat, stay hydrated, and function normally